NEW DELHI and MUNICH, June 7, 2023 /PRNewswire/ — Translumina, a global leader in interventional cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Munich-based Lamed GmbH. With this acquisition, Translumina has taken a step further towards its stated goal of providing a comprehensive cardiovascular portfolio at scale across key markets globally. […]
Financial
Bitterroot Bio Launches Out of Stealth with $145 Million Series A Financing to Develop Transformative Medicines in Cardio-immunology
Founders, Executive Team, and Advisors are recognized scientific and clinical pioneers in the fields of immunology and cardiology Series A financing co-led by ARCH Venture Partners and Deerfield Management with participation from GV, Koch Disruptive Technologies, Alexandria Venture Investments, and others PALO ALTO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — […]
Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
Bill Little, previously Chief Operating Officer (COO) of Neovasc, Inc. through its acquisition by Shockwave Medical in April 2023, will lead efforts to forge further strategic collaborations in newly created Executive Vice President (EVP) of Corporate Development and Strategy role Andrew Taylor joins as Chief Financial Officer (CFO) with over […]
Lexicon Announces Closing of Public Offering and Concurrent Private Placement, Including Full Exercise of Options to Purchase Additional Shares
Aggregate Gross Proceeds of $143.7 Million from Public Offering and Private Placement THE WOODLANDS, Texas, June 05, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the closing of Lexicon’s previously announced public offering and concurrent private placement of shares of its common stock. The closing included the […]
Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
HINGHAM, Mass., June 06, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering for the purchase and sale of 701,756 shares of the Company’s common stock at a purchase price of $2.1375 per share of common stock priced […]
Nuwellis Announces the Appointment of Mike McCormick to its Board of Directors
MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of patients suffering from fluid overload, today announced that Mike McCormick has been appointed to the company’s Board of Directors. Mr. McCormick’s vast experience includes more than 25 years of service […]
iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments
SAN FRANCISCO, June 06, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the appointment of Mojdeh Poul and Brian Yoor as directors to its Board effective June 1, 2023. “On behalf of the […]
GE HealthCare Technologies Inc. Commences Secondary Offering of 25,000,000 Shares
CHICAGO–(BUSINESS WIRE)–GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 25,000,000 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds […]
Conformal Medical Raises $35 Million in Oversubscribed Series D Round
The round was led by SPRIG Equity with participation from all major Series C investors NASHUA, N.H., June 5, 2023 /PRNewswire/ — Conformal Medical, Inc., a medical device company developing next-generation left atrial appendage occlusion (LAAO) technology, today announced the successful completion of its Series D funding round, raising a total of $35 million. “SPRIG Equity is focused on enabling transformative medical technology companies to achieve meaningful milestones, and more importantly, […]
Sensydia Secures $3M NIH Grant to Advance AI-Based Cardiac Assessment Platform
NIH STTR Fast-Track grant helps propel Sensydia’s non-invasive CPS platform building on recent funding round LOS ANGELES–(BUSINESS WIRE)–Non-invasive cardiac diagnostic company Sensydia announced today that it was awarded a Fast-Track Small Business grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). The award provides […]



